The Bulk Drug manufacturing industry is a phrase used to define a licensed product in bulk form, manufactured for use as an active pharmaceutical ingredient (API). An Active ingredient (AI) is the ingredient in a pharmaceutical drug or a pesticide that is biologically active.
Some medications and pesticide products may contain more than one active ingredient and depending on the complexity of the molecule required and synthesis of APIs might need multi-step complex chemistry utilizing a range of processing technologies. Schematic Industries are an experienced supplier to the Bulk Drug industry, offering a wide range of world-class processing equipment technologies and solutions that meet and exceed cGMP and cGAMP.
The main manufacturers of APIs include TAPI (Teva Active Pharmaceutical Ingredients), Dr. Reddy’s, Aurobindo, Cipla, Sandoz-Lek-Biochemie, Ranbaxy, Matrix and Sun. These API giants specialise in range of API-related fields in areas such as chemical synthesis, fermentation, chromatography, plant extraction, diagnostic kits and biotechnology products.
Given the incredible growth in the Indian API market, the 'Bulk Drug Manufacturers Association' (India) was formed in 1991. This is a body representing all the Bulk Drug manufacturers of India with Hyderabad as its Head Quarters.
The bulk drug industry is a place where drugs are produced in huge quantities and at a very large scale. The smallest of oversights can result in either potential disaster or significant revenue loss. Where failure of a single batch is a really big deal, our equipment, knowledge and quality of products can make a positive difference in how you can have guaranteed peace of mind. For further information, click here to go to our API summary page.